Patents by Inventor Steve B Cohen

Steve B Cohen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8710192
    Abstract: The present invention provides antibody antagonists against proprotein convertase subtilisin/kexin type 9a (“PCSK9”) and methods of using such antibodies.
    Type: Grant
    Filed: December 10, 2010
    Date of Patent: April 29, 2014
    Assignees: IRM LLC, Novartis AG
    Inventors: Sarah Rue, Steve B. Cohen, Jun Li, David Yowe
  • Publication number: 20110158999
    Abstract: The present invention provides antibodies or antigen-binding molecules that specifically recognize and antagonize human PAR1 receptor. Also provided in the invention are polynucleotides and vectors that encode such molecules and host cells that harbor the polynucleotides or vectors.
    Type: Application
    Filed: January 7, 2011
    Publication date: June 30, 2011
    Applicant: IRM LLC
    Inventors: Steve B. Cohen, Marc Nasoff
  • Publication number: 20110142849
    Abstract: The present invention provides antibody antagonists against proprotein convertase subtilisin/kexin type 9a (“PCSK9”) and methods of using such antibodies.
    Type: Application
    Filed: December 10, 2010
    Publication date: June 16, 2011
    Applicants: IRM LLC, NOVARTIS AG
    Inventors: SARAH RUE, STEVE B. COHEN, JUN LI, DAVID YOWE
  • Patent number: 7888483
    Abstract: The present invention provides antibodies or antigen-binding molecules that specifically recognize and antagonize human PAR1 receptor. Also provided in the invention are polynucleotides and vectors that encode such molecules and host cells that harbor the polynucleotides or vectors.
    Type: Grant
    Filed: July 17, 2007
    Date of Patent: February 15, 2011
    Assignee: IRM LLC
    Inventors: Steve B Cohen, Marc Nasoff